These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9541657)

  • 1. Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for electrophilic and non-electrophilic mechanisms.
    Henry B; Grant SG; Klopman G; Rosenkranz HS
    Mutat Res; 1998 Feb; 397(2):313-35. PubMed ID: 9541657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database.
    Grant SG; Zhang YP; Klopman G; Rosenkranz HS
    Mutat Res; 2000 Feb; 465(1-2):201-29. PubMed ID: 10708987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cytotoxicity on test results in the L5178Y TK+/- mouse lymphoma assay.
    Oberly TJ; Garriot ML
    Environ Mol Mutagen; 1996; 27(1):75-8. PubMed ID: 8625951
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
    Moore MM; Doerr CL
    Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viable chromosomal mutations affecting the TK locus in L5178Y/TK+/- mouse lymphoma cells: the other half of the assay.
    Clive D
    Ann N Y Acad Sci; 1983; 407():253-7. PubMed ID: 6410962
    [No Abstract]   [Full Text] [Related]  

  • 6. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci.
    Moore MM; Harrington-Brock K; Doerr CL; Dearfield KL
    Mutagenesis; 1989 Sep; 4(5):394-403. PubMed ID: 2687635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of tka(-)-1 and tkb(+)-1 alleles in L5178Y tk+/- mouse-lymphoma cells and spontaneous tk-/- mutants.
    Liechty MC; Rauchfuss HS; Lugo MH; Hozier JC
    Mutat Res; 1993 Apr; 286(2):299-307. PubMed ID: 7681542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of the L5178Y tk+/tk- mouse lymphoma cell forward mutation assay. II: 18 coded chemicals.
    McGregor DB; Brown A; Cattanach P; Edwards I; McBride D; Caspary WJ
    Environ Mol Mutagen; 1988; 11(1):91-118. PubMed ID: 3338442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic characterization of the L5178Y TK+/-3.7.2C mouse lymphoma cell line.
    Sawyer J; Moore MM; Clive D; Hozier J
    Mutat Res; 1985 Oct; 147(5):243-53. PubMed ID: 4047079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activity of 5 thiazole compounds in the Salmonella/microsome and mouse lymphoma TK+/- assays.
    Cameron TP; Hughes TJ; Kirby PE; Palmer KA; Fung VA; Dunkel VC
    Mutat Res; 1985; 155(1-2):17-25. PubMed ID: 3881663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative mutagenicity testing of bropirimine, 1. Induction of chromosome aberrations in CHO cells is not reflected in induction of mutation at the TK locus of L5178Y cells.
    Aaron CS; Petry TW; Thilagar A; Kumaroo PV; Kirby P
    Mutat Res; 1991 Jun; 252(3):221-8. PubMed ID: 2052002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Loss of Heterozygosity in Tk-Deficient Mutants from L5178Y Tk
    Guo X; Chen Y; Moore MM; Mei N
    Methods Mol Biol; 2020; 2102():251-270. PubMed ID: 31989560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of methyl bromide in a series of short-term tests.
    Kramers PG; Voogd CE; Knaap AG; van der Heijden CA
    Mutat Res; 1985; 155(1-2):41-7. PubMed ID: 3918260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mouse lymphoma assay.
    Lloyd M; Kidd D
    Methods Mol Biol; 2012; 817():35-54. PubMed ID: 22147567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
    Davies MJ; Phillips BJ; Rumsby PC
    Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation at the TK locus of mouse lymphoma L5178Y cells by 4CMB, 4HMB and BC.
    Ross CA; McGregor DB
    Mutat Res; 1982; 100(1-4):249-51. PubMed ID: 7057755
    [No Abstract]   [Full Text] [Related]  

  • 18. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
    Clark LS; Hart DW; Vojta PJ; Harrington-Brock K; Barrett JC; Moore MM; Tindall KR
    Mutagenesis; 1998 Sep; 13(5):427-34. PubMed ID: 9800187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.